RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..3 of 3 - per page
Order by
Tackling challenges of poor solubility
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Use of Biological Surfactant as Anti-flammatory Agent and Tissue Preservative Solution
Cancer immunotherapy using dendritic cells, and iii) Camel recombinant antibodies for FoxP3, Mucl & CEA. More
HY209_SHAPERON Inc
Sodium taurodeoxycholate) for the treatment of sepsis More
Displaying 1..3 of 3 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Sepsis Therapy Area Pipeline Report
Nov 2010 - 85 pages - $1,495
Haemophilia and Blood Coagulation Disorders Therapy Area Pipeline Report
Nov 2010 - 330 pages - $1,495
Sepsis - Pipeline Review, Q4 2010
Dec 2010 - 63 pages - $500
R&D Trends: Sepsis - Improvements in clinical trial design and advances in biomarker research hold the key to a tailored approach to sepsis therapy
Apr 2011 - 40 pages - $3,800
Epidemiology: Sepsis – The incidence of severe sepsis is on the rise due to the dramatic aging populations across the developed world
Mar 2011 - 33 pages - $5,700
Stakeholder Opinions: Sepsis - The Critical Care Community Gains Critical Mass
Mar 2008 - 124 pages - $3,800
Sepsis - Pipeline Review, H2 2011
Aug 2011 - 157 pages - $500
Sepsis Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Jul 2011 - 84 pages - $2,000
Sepsis - Pipeline Review, Q2 2011
Apr 2011 - 104 pages - $500
Deals and alliances in blood and lymphatic diseases
Jun 2006 - 556 pages - $2,495
More Related Market Research Reports >>>

Your selection

Therapeutic target
Blood and forming organs del
Sepsis del
Development phase
Early Stage del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us